POMDOCTOR Ltd (NASDAQ:POM) Sees Significant Growth in Short Interest

POMDOCTOR Ltd (NASDAQ:POM) was the recipient of a significant growth in short interest in the month of October. As of October 30th, there was short interest totaling 250,448 shares, a growth of 1,013.1% from the October 15th total of 22,500 shares. Based on an average daily trading volume, of 11,332,816 shares, the short-interest ratio is presently 0.0 days. Approximately 10.8% of the company’s shares are short sold.

POMDOCTOR Stock Performance

Shares of NASDAQ:POM traded up $0.05 during midday trading on Tuesday, hitting $1.60. 121,646 shares of the company’s stock traded hands, compared to its average volume of 4,044,697. POMDOCTOR has a twelve month low of $0.43 and a twelve month high of $102.42.

POMDOCTOR (NASDAQ:POM) last issued its earnings results on Tuesday, September 29th. The company reported ($7.30) earnings per share for the quarter. The firm had revenue of $13.62 million during the quarter.

POMDOCTOR Company Profile

Our mission is to provide effective prevention and treatment solutions to alleviate patients’ sufferings from illnesses. Our vision is to become the most trustworthy medical and healthcare services platform. We are a leading online medical services platform for chronic diseases in China, ranking sixth on China’s Internet hospital market measured by the number of contracted doctors in 2022, according to Frost & Sullivan. As of December 31, 2023 and 2024, the cumulative number of contracted doctors stabilized at over 212,800, while the transacting patients increased from 654,817 as of December 31, 2023 to 699,338 as of December 31, 2024.